Identification of the effects of pathogenic genetic variations of human CYP2C9 and CYP2D6: an in silico approach

References

• Elewa, H.; Awaisu, A. Pharmacogenomics in Pharmacy Practice: Current Perspectives. Integr. Pharm. Res. Pract. 2019, 8, 97–104. DOI: 10.2147/IPRP.S180154.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Vicente, A. E.; Lumbreras, E.; Hernández, J. M.; Martín, M.; Calles, A.; Otín, C. L.; Algarra, S. M.; Páez, D.; Taron, M. Pharmacogenetics and Pharmacogenomics as Tools in Cancer Therapy. Drug Metab. Pers. Ther. 2016, 31, 25–34. DOI: 10.1515/dmpt-2015-0042.
   PubMedGoogle Scholar
• Groves, J. T. Cytochrome P450 Enzymes: Understanding the Biochemical Hieroglyphs [Version 1; Referees: 3 Approved]. F1000Res 2015, 4, 178. DOI: 10.12688/f1000research.6314.1.
   Google Scholar
• Zanger, U. M.; Schwab, M. Cytochrome P450 Enzymes in Drug Metabolism: Regulation of Gene Expression, Enzyme Activities, and Impact of Genetic Variation. Pharmacol. Ther. 2013, 138, 103–141. DOI: 10.1016/j.pharmthera.2012.12.007.
   PubMed Web of Science ®Google Scholar
• Daly, A. K.; Rettie, A. E.; Fowler, D. M.; Miners, J. O. Pharmacogenomics of CYP2C9: Functional and Clinical Considerations. J. Pers. Med. 2017, 8, 1. DOI: 10.3390/jpm8010001.
   PubMed Web of Science ®Google Scholar
• Leitão, L. P. C.; Souza, T. P.; Rodrigues, J. C. G.; Fernandes, M. R.; Santos, S.; Santos, N. P. C. The Metabolization Profile of the CYP2D6 Gene in Amerindian Populations: A Review. Genes (Basel) 2020, 11, 262. DOI: 10.3390/genes11030262.
   PubMed Web of Science ®Google Scholar
• Owen, R. P.; Sangkuhl, K.; Klein, T. E.; Altman, R. B. Cytochrome P450 2D6. Pharmacogenet. Genomics 2009, 19, 559–562. DOI: 10.1097/FPC.0b013e32832e0e97.
   PubMed Web of Science ®Google Scholar
• Wojtczak, A.; Wojtczak, M.; Skrętkowicz, J. The Relationship Between Plasma Concentration of Metoprolol and CYP2D6 Genotype in Patients with Ischemic Heart Disease. Pharmacol. Rep. 2014, 66, 511–514. DOI: 10.1016/j.pharep.2013.12.010.
   PubMed Web of Science ®Google Scholar
• Manikandan, P.; Nagini, S. Cytochrome P450 Structure, Function and Clinical Significance: A Review. Curr. Drug Targets 2018, 19, 38–54. DOI: 10.2174/1389450118666170125144557.
   PubMed Web of Science ®Google Scholar
• McDonnell, A. M.; Dang, C. H. Basic Review of the Cytochrome P450 System. J. Adv. Pract. Oncol. 2013, 4, 263–268. DOI: 10.6004/jadpro.2013.4.4.7.
   PubMedGoogle Scholar
• Bhagwat, M. Searching NCBI’s dbSNP Database. Curr. Protoc. Bioinformatics 2010, Chapter 1, Unit 1.19. CHAPTER1, Unit–1.19. DOI: 10.1002/0471250953.bi0119s32.
   PubMedGoogle Scholar
• Sim, N. L.; Kumar, P.; Hu, J.; Henikoff, S.; Schneider, G.; Ng, P. C. SIFT Web Server: Predicting Effects of Amino Acid Substitutions on Proteins. Nucleic Acids Res. 2012, 40, W452–W457. DOI: 10.1093/nar/gks539.
   PubMed Web of Science ®Google Scholar
• Naveed, M.; Tehreem, S.; Mehboob, M. Z. In-Silico Analysis of Missense SNPs in Human HPPD Gene Associated with Tyrosinemia Type III and Hawkinsinuria. Comput. Biol. Chem. 2019, 80, 284–291. DOI: 10.1016/j.compbiolchem.2019.04.007.
   PubMed Web of Science ®Google Scholar
• Adzhubei, I.; Jordan, D. M.; Sunyaev, S. R. Predicting Functional Effect of Human Missense Mutations Using PolyPhen-2. Curr. Protoc. Hum. Genet. 2013, Chapter 7, Unit7.20. Chapter 7, Unit7.20. DOI: 10.1002/0471142905.hg0720s76.
   PubMedGoogle Scholar
• Capriotti, E.; Martelli, P. L.; Fariselli, P.; Casadio, R. Blind Prediction of Deleterious Amino Acid Variations with SNPs&GO. Hum. Mutat. 2017, 38, 1064–1071. DOI: 10.1002/humu.23179.
   PubMed Web of Science ®Google Scholar
• Choi, Y.; Chan, A. P. PROVEAN Web Server: A Tool to Predict the Functional Effect of Amino Acid Substitutions and Indels. Bioinformatics 2015, 31, 2745–2747. DOI: 10.1093/bioinformatics/btv195.
   PubMed Web of Science ®Google Scholar
• Capriotti, E.; Fariselli, P. PhD-SNPg: A Webserver and Lightweight Tool for Scoring Single Nucleotide Variants. Nucleic Acids Res. 2017, 45, W247–W252. DOI: 10.1093/nar/gkx369.
   PubMed Web of Science ®Google Scholar
• Gerasimavicius, L.; Liu, X.; Marsh, J. A. Identifcation of Pathogenic Missense Mutations Using Protein Stability Predictors. Sci. Rep. 2020, 10, 15387. DOI: 10.1038/s41598-020-72404-w.
   PubMed Web of Science ®Google Scholar
• Ashkenazy, H.; Abadi, S.; Martz, E.; Chay, O.; Mayrose, I.; Pupko, T.; Ben-Tal, N. ConSurf 2016: An Improved Methodology to Estimate and Visualize Evolutionary Conservation in Macromolecules. Nucleic Acids Res. 2016, 44, W344–W350. DOI: 10.1093/nar/gkw408.
   PubMed Web of Science ®Google Scholar
• Geourjon, C.; Deléage, G. SOPMA: Significant Improvements in Protein Secondary Structure Prediction by Consensus Prediction from Multiple Alignments. Comput. Appl. Biosci. 1995, 11, 681–684. DOI: 10.1093/bioinformatics/11.6.681.
   PubMedGoogle Scholar
• Klausen, M. S.; Jespersen, M. C.; Nielsen, H.; Jensen, K. K.; Jurtz, V. I.; Sønderby, C. K.; Sommer, M. O. A.; Winther, O.; Nielsen, M.; Petersen, B.; Marcatili, P. NetSurfP‐2.0: Improved Prediction of Protein Structural Features by Integrated Deep Learning. Proteins 2019, 87, 520–527. DOI: 10.1002/prot.25674.
   PubMed Web of Science ®Google Scholar
• Hewett, M.; Oliver, D. E.; Rubin, D. L.; Easton, K. L.; Stuart, J. M.; Altman, R. B.; Klein, T. E. PharmGKB: The Pharmacogenetics Knowledge Base. Nucleic Acids Res. 2002, 30, 163–165. DOI: 10.1093/nar/30.1.163.
   PubMed Web of Science ®Google Scholar
• Twardowschy, C. A.; Werneck, L. C.; Scola, R. H.; De Paola, L.; Silvado, C. E. CYP2C9 Polymorphism in Patients with Epilepsy: Genotypic Frequency Analyzes and Phenytoin Adverse Reactions Correlation. Arq. Neuropsiquiatr. 2011, 69, 153–158. DOI: 10.1590/s0004-282x2011000200002.
   PubMed Web of Science ®Google Scholar
• Okat, Z.; Yaman, K.; Ciftci, K. U.; Toplayıcı, S.; Kurt, E.; Taga, Y. Determination of CYP2D6*3 and *4 Allele Frequency Among Turkish Population. J. Surg. Med. 2018, 2, 210–214. DOI: 10.28982/josam.416309.
   Google Scholar
• Taylor, C.; Crosby, I.; Yip, V.; Maguire, P.; Pirmohamed, M.; Turner, R. M. A Review of the Important Role of CYP2D6 in Pharmacogenomics. Genes (Basel) 2020, 11, 1295. DOI: 10.3390/genes11111295.
   PubMed Web of Science ®Google Scholar
• Subbiah, H. V.; Babu, P. R.; Subbiah, U. In Silico Analysis of Non-Synonymous Single Nucleotide Polymorphisms of Human DEFB1 Gene. Egypt J. Med. Hum. Genet. 2020, 21, 66. DOI: 10.1186/s43042-020-00110-3.
   Google Scholar
• Makowska, M.; Smolarz, B.; Bryś, M.; Forma, E.; Romanowicz, H. An Association Between the rs1799853 and rs1057910 Polymorphisms of CYP2C9, the rs4244285 Polymorphism of CYP2C19 and the Prevalence Rates of Drug-Resistant Epilepsy in Children. Int. J. Neurosci. 2021, 131, 1147–1154. DOI: 10.1080/00207454.2020.1781110.
   PubMed Web of Science ®Google Scholar
• Perwitasari, D. A.; Faridah, IN.; Maliza, R.; Dania, H.; Irham, L. M. Identification of SNP rs1799853 of CYP2C9 Gene and Blood Sugar Levels In Diabetic Patients. AJPT 2021, 09, 1–4.
   Google Scholar
• Cho, M. A.; Yoon, J. G.; Kim, V.; Kim, H.; Lee, R.; Lee, M. G.; Kim, D. Functional Characterization of Pharmcogenetic Variants of Human Cytochrome P450 2C9 in Korean Populations. Biomol. Ther. (Seoul) 2019, 27, 577–583. DOI: 10.4062/biomolther.2019.112.
   PubMed Web of Science ®Google Scholar
• Khlifi, R.; Chakroun, A.; Hamza-Chaffai, A.; Rebai, A. Association of CYP1A1 and CYP2D6 Gene Polymorphisms with Head and Neck Cancer in Tunisian Patients. Mol. Biol. Rep. 2014, 41, 2591–2600. DOI: 10.1007/s11033-014-3117-6.
   PubMed Web of Science ®Google Scholar
• Loganathan, L.; Kuriakose, B. B.; Mushfiq, S.; Muthusamy, K. Mechanistic Insights on nsSNPs on Binding Site of Renin and Cytochrome P450 Proteins: A Computational Perceptual Study for Pharmacogenomics Evaluation. J. Cell Biochem. 2021, 122, 1460–1474. DOI: 10.1002/jcb.30069.
   PubMed Web of Science ®Google Scholar
• Dalton, R.; Lee, S. B.; Claw, K. G.; Prasad, B.; Phillips, B. R.; Shen, D. D.; Wong, L. H.; Fade, M.; McDonald, M. G.; Dunham, M. J.; et al. Interrogation of CYP2D6 Structural Variant Alleles Improves the Correlation Between CYP2D6 Genotype and CYP2D6-Mediated Metabolic Activity. Clin. Transl. Sci. 2020, 13, 147–156. DOI: 10.1111/cts.12695.
   PubMed Web of Science ®Google Scholar
• Huang, H.; Dong, Y.; Xu, Y.; Deng, Y.; Zhang, C.; Liu, S.; Chen, M.; Liu, Y. The Association of CYP2D6 Gene Polymorphisms in the Full-Length Coding Region with Higher Recurrence Rate of Vivax Malaria in Yunnan Province, China. Malar. J. 2021, 20, 160. DOI: 10.1186/s12936-021-03685-3.
   PubMed Web of Science ®Google Scholar
• Hossain, S.; Roy, A. S.; Islam, M. S. In Silico Analysis Predicting Effects of Deleterious SNPs of Human RASSF5 Gene on Its Structure and Functions. Sci. Rep. 2020, 10, 14542. DOI: 10.1038/s41598-020-71457-1.
   PubMed Web of Science ®Google Scholar
• Zhang, M.; Huang, C.; Wang, Z.; Lv, H.; Li, X. In Silico Analysis of Non-Synonymous Single Nucleotide Polymorphisms (nsSNPs) in the Human GJA3 Gene Associated with Congenital Cataract. BMC Mol. Cell Biol. 2020, 21, 12. DOI: 10.1186/s12860-020-00252-7.
   PubMed Web of Science ®Google Scholar